Retrospective analysis of stage IV advanced gastric cancer treated with S-1 or other chemotherapy.

Background: We retrospectively analyzed the influence of various clinicopathologic factors on the survival of patients treated with chemotherapy.

Methods: A retrospective analysis was made of 110 patients with stage IV gastric cancer who were treated from January 1996 to June 2004.

Results: Median survival time was 429 days for patients treated with S-1 therapy and 236 days for patients without S-1 therapy.

[A case of advanced esophageal cancer with suspected tracheoesophageal fistula that responded to chemoradiotherapy].

Chemoradiotherapy combined cisplatin, 5-FU and radiation was carried out in an advanced esophageal cancer with suspected tracheoesophageal fistula after insertion of an expandable metallic stent. Regression of the primary tumor was observed, and oral intake could be started. Chemoradiotherapy after insertion of the expandable metallic stent was useful in this case of advanced esophageal cancer with suspected tracheoesophageal fistula.